Android app Apple app link

Lexeo Therapeutics (LXEO) Gets a PT Cut to $13 by H.C. Wainwright Due to Equity Raise

By Yahoo! Finance   |   1 month ago
Lexeo Therapeutics (LXEO) Gets a PT Cut to $13 by H.C. Wainwright Due to Equity Raise

Lexeo Therapeutics Inc. (NASDAQ:LXEO) is a promising stock with recent price target adjustments due to equity raises. Analysts see potential in the company's genetic medicine focus. Consider other AI stocks for greater upside potential and lower risk.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.